PBSV (Pharma-Bio Serv) ROCE %: 5.61% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PBSV Pharma-Bio Serv Inc PBSV
43 GF Score
Price $0.42
GF Value $0.58
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pharma-Bio Serv ROCE %?

Pharma-Bio Serv PBSV -27.16% 43 ROCE % is 5.61% as of Apr. 2026. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pharma-Bio Serv's annualized ROCE % for the quarter that ended in Apr. 2026 was 5.61%.

Pharma-Bio Serv  (OTCPK:PBSV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pharma-Bio Serv ROCE % Related Terms

Pharma-Bio Serv ROCE % Historical Data

* Premium members only.

The historical data trend for Pharma-Bio Serv's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma-Bio Serv ROCE % Chart

Pharma-Bio Serv Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.27 5.91 6.16 -8.01 -4.85

Pharma-Bio Serv Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.16 -10.44 -4.46 -3.43 5.61
PBSV
43GF Score
Pharma-Bio Serv Inc PBSV
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma-Bio Serv ROCE % Calculation

Pharma-Bio Serv's annualized ROCE % for the fiscal year that ended in Oct. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Oct. 2025 )  (A: Oct. 2024 )(A: Oct. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Oct. 2025 )  (A: Oct. 2024 )(A: Oct. 2025 )
=-0.638/( ( (16.292 - 1.887) + (13.653 - 1.739) )/ 2 )
=-0.638/( (14.405+11.914)/ 2 )
=-0.638/13.1595
=-4.85 %

Pharma-Bio Serv's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=0.58/( ( (13.548 - 3.31) + (11.499 - 1.045) )/ 2 )
=0.58/( ( 10.238 + 10.454 )/ 2 )
=0.58/10.346
=5.61 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.61% mean?
Pharma-Bio Serv (PBSV) has a ROCE % of 5.61% as of Apr. 2026.
Is Pharma-Bio Serv's ROCE % too high?
Pharma-Bio Serv's current ROCE % is 5.61%. The Healthcare Providers & Services industry median ROCE % is 6.41. Pharma-Bio Serv's value of 5.61% is 12.5% below this industry median. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's ROCE % compare to MGRX and BFRG?
Pharma-Bio Serv's ROCE % of 5.61% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Pharma-Bio Serv's value of 5.61% is 12.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma-Bio Serv's current ROCE % of 5.61% is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma-Bio Serv's current ROCE % is 5.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current ROCE % is 5.61% and 12.5% below the Healthcare Providers & Services industry median of 6.41. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current ROCE % is 5.61% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma-Bio Serv (PBSV) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued. The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58. GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.

Key valuation signals for PBSV:

  • ROCE %: 5.61%
  • GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
  • GF Score™: 43/100 with 1 warning sign
  • Industry Position: 12.5% below the Healthcare Providers & Services median

No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma-Bio Serv Business Description

Address No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score

Get the complete analysis for PBSV

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.58
GF Value